|
| 36594261 | Cross-neutralization and viral fitness of SARS-CoV-2 Omicron sublineages. | Emerg Microbes Infect | 2023 |
| 37863935 | A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity. | NPJ Vaccines | 2023 |
| 38082099 | SARS-COV-2 Omicron variants conformationally escape a rare quaternary antibody binding mode. | Commun Biol | 2023 |
| 38053173 | Dengue and Zika RNA-RNA interactomes reveal pro- and anti-viral RNA in human cells. | Genome Biol | 2023 |
| 37824708 | Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1. | Emerg Microbes Infect | 2023 |
| 37766263 | An Integrated Research-Clinical BSL-2 Platform for a Live SARS-CoV-2 Neutralization Assay. | Viruses | 2023 |
| 37343373 | Metformin restrains ZIKV replication and alleviates virus-induced inflammatory responses in microglia. | Int Immunopharmacol | 2023 |
| 37114433 | Mutations in SARS-CoV-2 variant nsp6 enhance type-I interferon antagonism. | Emerg Microbes Infect | 2023 |
| 37111440 | Oral Supplementation with AHCC<sup>®</sup>, a Standardized Extract of Cultured <i>Lentinula edodes</i> Mycelia, Enhances Host Resistance against SARS-CoV-2 Infection. | Pathogens | 2023 |
| 37003304 | The multiple roles of nsp6 in the molecular pathogenesis of SARS-CoV-2. | Antiviral Res | 2023 |
| 37002158 | Corrigendum to "Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics" "Antiviral Research 209 (2023)/105484". | Antiviral Res | 2023 |
| 37131704 | A single-dose of intranasal vaccination with a live-attenuated SARS-CoV-2 vaccine candidate promotes protective mucosal and systemic immunity. | bioRxiv | 2023 |
| 37034621 | S:D614G and S:H655Y are gateway mutations that act epistatically to promote SARS-CoV-2 variant fitness. | bioRxiv | 2023 |
| 36625591 | Determinants and Mechanisms of the Low Fusogenicity and High Dependence on Endosomal Entry of Omicron Subvariants. | mBio | 2023 |
| 36817862 | Clinical Efficacy of Nutritional Intervention Combined with Muscle Exercise on Sarcopenia Patients with Femoral Fracture: A Pilot Randomized Controlled Trial. | Biomed Res Int | 2023 |
| 36624294 | Publisher Correction: SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry. | Nature | 2023 |
| 36652353 | Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years. | N Engl J Med | 2023 |
| 36473500 | Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster. | Nat Med | 2023 |
| 36747034 | Author Correction: SARS-CoV-2 disrupts host epigenetic regulation via histone mimicry. | Nature | 2023 |
| 36508969 | Design, synthesis, and pharmacological evaluations of pyrrolo[1,2-a]quinoxaline-based derivatives as potent and selective sirt6 activators. | Eur J Med Chem | 2023 |
| 36508877 | Identification of an immunogenic epitope and protective antibody against the furin cleavage site of SARS-CoV-2. | EBioMedicine | 2023 |
| 36734885 | Neutralization of BA.4-BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine. | N Engl J Med | 2023 |
| 36503013 | Discovery of lead natural products for developing pan-SARS-CoV-2 therapeutics. | Antiviral Res | 2023 |
| 36929216 | Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds. | J Pediatric Infect Dis Soc | 2023 |
| 36791162 | Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age. | N Engl J Med | 2023 |
| 36657881 | Reverse genetic systems of SARS-CoV-2 for antiviral research. | Antiviral Res | 2023 |
| 34818667 | The N501Y spike substitution enhances SARS-CoV-2 infection and transmission. | Nature | 2022 |
| 35739094 | Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine. | Nat Commun | 2022 |
| 35550680 | Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant. | Cell Rep | 2022 |
| 35835291 | Allosteric inhibitors of the main protease of SARS-CoV-2. | Antiviral Res | 2022 |
| 35728038 | Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis. | PLoS Pathog | 2022 |
| 35792746 | Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by three doses of BNT162b2 vaccine or BA.1 infection. | Emerg Microbes Infect | 2022 |
| 35465974 | The arrival of SARS-CoV-2-neutralizing antibodies in a currently available commercial immunoglobulin. | J Allergy Clin Immunol | 2022 |
| 35396516 | BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants. | NPJ Vaccines | 2022 |
| 35532238 | Remdesivir and GS-441524 Retain Antiviral Activity against Delta, Omicron, and Other Emergent SARS-CoV-2 Variants. | Antimicrob Agents Chemother | 2022 |
| 35525335 | Intravenous delivery of GS-441524 is efficacious in the African green monkey model of SARS-CoV-2 infection. | Antiviral Res | 2022 |
| 35688318 | A modified porous silicon microparticle potentiates protective systemic and mucosal immunity for SARS-CoV-2 subunit vaccine. | Transl Res | 2022 |
| 35746682 | A Single-Round Infection Fluorescent SARS-CoV-2 Neutralization Test for COVID-19 Serological Testing at a Biosafety Level-2 Laboratory. | Viruses | 2022 |
| 35618703 | Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2. | Nat Commun | 2022 |
| 36402138 | Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine. | Cell Rep | 2022 |
| 36468872 | Correction for Zhou et al., "Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections". | mBio | 2022 |
| 36074821 | The human disease gene LYSET is essential for lysosomal enzyme transport and viral infection. | Science | 2022 |
| 36179934 | Flavivirus NS4B protein: Structure, function, and antiviral discovery. | Antiviral Res | 2022 |
| 35906244 | Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2. | NPJ Vaccines | 2022 |
| 36138032 | Engineering SARS-CoV-2 specific cocktail antibodies into a bispecific format improves neutralizing potency and breadth. | Nat Commun | 2022 |
| 35963863 | Cross-neutralization and cross-protection among SARS-CoV-2 viruses bearing different variant spikes. | Signal Transduct Target Ther | 2022 |
| 36032971 | Integrated multi-omics analyses identify key anti-viral host factors and pathways controlling SARS-CoV-2 infection. | Res Sq | 2022 |
| 35988543 | Antibody escape and cryptic cross-domain stabilization in the SARS-CoV-2 Omicron spike protein. | Cell Host Microbe | 2022 |
| 35896528 | A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions. | Nat Commun | 2022 |
| 36229471 | Publisher Correction: A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions. | Nat Commun | 2022 |